Polar Body Biopsy for Preimplantation Genetic Screening
Polar Body
Polar Body Biopsy (PB) for Preimplantation Genetic Screening
1 other identifier
interventional
33
1 country
1
Brief Summary
People with infertility undergoing in vitro fertilization (IVF) can test the embryos using a method called preimplantation genetic screening (PGS) before they are implanted in the uterus to possibly increase their chances of having a successful pregnancy. One or more cells are removed from the embryo. The chromosomes inside the cells are then tested to identify normal or aneuploid embryo(s). The investigators propose to evaluate a test called micro array analysis on the chromosomes of the first polar body. This method tests part of the egg that would normally be lost and may help us choose the embryo most likely to become a healthy baby.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 16, 2012
CompletedFirst Posted
Study publicly available on registry
April 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedJune 11, 2015
June 1, 2015
10 months
March 16, 2012
June 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of polar biopsy and preimplantation genetic analysis
To determine the efficacy of PB biopsy and analysis by comparing the PB results to the FISH/microarray results
1 year
Secondary Outcomes (1)
Safety of polar biopsy
1 year
Study Arms (1)
Polar Body Biopsy with PGS
EXPERIMENTALPolar Body Biopsy with Pre implantation genetic screening
Interventions
PB biopsy and analysis by comparing the PB results to the FISH/microarray results
Eligibility Criteria
You may qualify if:
- Are undergoing IVF/Intracytoplasmic sperm injection(ICSI)
- Are considering preimplantation genetic screening for aneuploidy
- Are between ages 18 and 42 inclusive (female partner)
You may not qualify if:
- Using sperm from a testicular source
- Fewer than 10 oocytes retrieved
- Fewer than 6 oocytes fertilized normally
- Complete fertilization failure (no oocytes fertilize)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ronald O. Perelmand and Claudia Cohen Center for Reproductive Medicine
New York, New York, 10021, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glenn Schattman
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2012
First Posted
April 10, 2012
Study Start
September 1, 2011
Primary Completion
July 1, 2012
Study Completion
December 1, 2014
Last Updated
June 11, 2015
Record last verified: 2015-06